Trial intelligence / Profile preview

Analgesic Efficacy of Single-shot Adductor Canal Block With Levobupivacaine and Dexmedetomidine in Total Knee Arthroplasty

NCT04968392Phase 3Completed

Sponsor
Assiut University
Start
Mar 2019
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Time to the first analgesia rescue call at 24 hours. Started Mar 2019; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04968392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04968392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call